Literature DB >> 26932930

Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance.

Pei-Chi Chan1, Fone-Ching Hsiao2, Hao-Ming Chang3, Martin Wabitsch4, Po Shiuan Hsieh5.   

Abstract

We examined the involvement of adipocyte cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2)-prostaglandin E receptor (EP)3-mediated signaling during hypertrophy and hypoxia in the development of obesity-associated adipose tissue (AT) inflammation and insulin resistance. The experiments were conducted with high-fat diet (HFD)-induced obese rats, db/db mice, human subjects, and 3T3-L1 and the human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes; the groups were treated with selective inhibitors of COX-2 [celecoxib 30 mg/kg, half maximal inhibitory concentration (IC50) ≈ 0.04 µM] and EP3 (L-798106 100 µg/kg, IC50 ≈ 0.5 µM) or a short interfering RNA. There were strong, positive correlations between adipocyte COX-2 and EP3 gene expressions and the AT TNF-α and monocyte chemotactic protein-1 contents and the homeostatic model assessment for insulin resistance in HFD-induced obese rats, as well as body mass index in human subjects. Treatment with COX-2 and EP3 inhibitors significantly reversed AT inflammatory gene and protein expressions (-50%) and impaired glucose and insulin tolerance in db/db mice. COX-2 inhibition diminished the chemotaxis of adipocytes isolated from HFD rats to macrophages and T cells. Targeting inhibition of adipocyte COX-2 and EP3 during hypertrophy and hypoxia reversed the release of the augmented proinflammatory adipokines and the diminished adiponectin and also suppressed NF-κB and hypoxia-inducible factor-1α transcription activation. These findings suggest that adipocyte COX-2 PGE2-EP3-mediated signaling is crucially involved in the development of obesity-associated AT inflammation and insulin resistance.-Chan, P.-C., Hsiao, F.-C., Chang, H.-M., Wabitsch, M., Hsieh, P. S. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance. © FASEB.

Entities:  

Keywords:  EP3; adipocyte hypertrophy; cyclooxygenase-2 activation

Mesh:

Substances:

Year:  2016        PMID: 26932930     DOI: 10.1096/fj.201500127

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 2.  Free fatty acid G-protein coupled receptor signaling in M1 skewed white adipose tissue macrophages.

Authors:  Warren Antonio Vieira; Hanél Sadie-Van Gijsen; William Frank Ferris
Journal:  Cell Mol Life Sci       Date:  2016-05-12       Impact factor: 9.261

Review 3.  The Beta Cell in Type 2 Diabetes.

Authors:  Ashley A Christensen; Maureen Gannon
Journal:  Curr Diab Rep       Date:  2019-08-09       Impact factor: 4.810

Review 4.  The EP3 Receptor/Gz Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular Disease.

Authors:  Michael D Schaid; Jaclyn A Wisinski; Michelle E Kimple
Journal:  AAPS J       Date:  2017-06-05       Impact factor: 4.009

Review 5.  Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?

Authors:  Lia E Taylor; Lindsey A Ramirez; Jacqueline B Musall; Jennifer C Sullivan
Journal:  Br J Pharmacol       Date:  2019-08-19       Impact factor: 8.739

Review 6.  20 Years with SGBS cells - a versatile in vitro model of human adipocyte biology.

Authors:  Daniel Tews; Rolf E Brenner; Reiner Siebert; Klaus-Michael Debatin; Pamela Fischer-Posovszky; Martin Wabitsch
Journal:  Int J Obes (Lond)       Date:  2022-08-19       Impact factor: 5.551

7.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

8.  Prostaglandin Endoperoxide H Synthase-2 (PGHS-2) Variants and Risk of Obesity and Microvascular Dysfunction Among Tunisians: Relevance of rs5277 (306G/C) and rs5275 (8473T/C) Genetic Markers.

Authors:  Ahlem Touir; Soumaya Boumiza; Hela Ben Nasr; Sarra Bchir; Zouhair Tabka; Xavier Norel; Karim Chahed
Journal:  Biochem Genet       Date:  2021-04-30       Impact factor: 1.890

9.  Prostate Tumor Cell-Derived IL1β Induces an Inflammatory Phenotype in Bone Marrow Adipocytes and Reduces Sensitivity to Docetaxel via Lipolysis-Dependent Mechanisms.

Authors:  Mackenzie K Herroon; Jonathan D Diedrich; Erandi Rajagurubandara; Carly Martin; Krishna R Maddipati; Seongho Kim; Elisabeth I Heath; James Granneman; Izabela Podgorski
Journal:  Mol Cancer Res       Date:  2019-09-27       Impact factor: 5.852

10.  F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes.

Authors:  M T Kaartinen; M Arora; S Heinonen; A Hang; A Barry; J Lundbom; A Hakkarainen; N Lundholm; A Rissanen; J Kaprio; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2020-11-21       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.